Justice Approves Cigna/Express Scripts Merger Without Conditions

By John Wilkerson / September 17, 2018 at 5:04 PM
The Justice Department’s antitrust division approved, without conditions, Cigna’s proposed $67 billion purchase of Express Scripts , despite concerns that allowing the insurer and pharmacy benefit manager to merge could lead to higher drug prices. Senate Judiciary Chair Chuck Grassley urged Justice to conduct a “robust analysis” because he said the merger could either give plans and pharmacy benefit managers more power to control drug prices or create barriers to competition in both the health insurance and pharmacy benefit manager...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.